Related Experiment Video
Updated: Aug 6, 2026
08:13
Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
Published on: January 20, 2019
BN-52021 protects guinea-pig from heart anaphylaxis
Pharmacological Research Communications
|December 1, 1988
Summary
BN-52021, a ginkgolide, protects guinea-pig hearts from allergic reactions by reducing mediator release. This suggests platelet-activating factor (PAF) plays a key role in anaphylaxis or BN-52021 has broad effects.
Area of Science:
- Immunology
- Pharmacology
Background:
- Anaphylaxis involves the release of chemical mediators.
- Platelet-activating factor (PAF) is implicated in allergic reactions.
Purpose of the Study:
- To investigate the protective effects of BN-52021 against immunological reactions in vitro.
- To determine the impact of BN-52021 on mediator release during anaphylaxis.
Main Methods:
- Utilized an actively sensitized guinea-pig heart model.
- Measured the release of histamine, thromboxane-A2, and slow-reacting substance of anaphylaxis.
Main Results:
- BN-52021 preserved the guinea-pig heart from immunological damage.
- BN-52021 significantly reduced mediator release in a dose-dependent manner.
- Histamine release was particularly inhibited by BN-52021.
Conclusions:
- BN-52021 demonstrates protective effects against anaphylaxis in vitro.
- Results highlight the potential role of PAF in guinea pig anaphylaxis.
- BN-52021 may possess a broad spectrum of pharmacological activity.
